Postdoctoral associate Phillip Nadeau speaks with CBC reporter Nora Young about a new ingestible electronic device developed by MIT researchers that could potentially be used to transmit patient data or deliver medications. Young explains that the new device “doesn't require a battery, because it's able to create an electrical current from the acid in your stomach.”
Researchers at MIT have designed a new living material infused with cells that could one day be used as a wearable sensor, writes Brooks Hays for UPI. The researchers used the new material to “design gloves and bandages that light up when they come in contact with target chemicals.”
Research affiliate Giovanni Traverso speaks with Ira Flatow of Science Friday about a new ingestible device powered by stomach acid. “When you start thinking about keeping a system inside of the body for a long time,” Traverso explains, “powering that system becomes a challenge, and that’s exactly what we tried to aim to address here with this study.”
MIT researchers have developed an ingestible device that is powered by stomach acid and can deliver drugs for up to one week, reports Brooks Hays of UPI. "Our work helps pave the way toward a new era of pill-sized electronics, which can operate over the course of weeks or even months in the gastrointestinal tract,” says Giovanni Traverso, a research affiliate at the Koch Institute.
MIT researchers have developed a new drug capsule that can deliver doses of medication over the course of several weeks, reports Robby Berman for Slate. Berman explains that the star-shaped device is like “a little pharmacy stationed in the stomach, ready to dispense doses at the desired times.”
Prof. Robert Langer speaks with Kathryn Nave of Wired about the future of drug delivery. Langer explains that a problem facing medical professionals is that many drugs are not taken regularly or as prescribed, and describes how he is developing a “long-acting pill that you could swallow to release the right drug dosage for weeks.”
MIT researchers have found that reduced plasticity in the brains of people with dyslexia may explain why they experience difficulties with reading and with processing spoken speech, writes Kevin Murnane of Forbes. Murnane explains that the findings “indicate that dyslexia is not just about reading. It involves a reduction in neural adaptation to a variety of perceptual stimuli.”
TIME reporter Alice Park writes about a study by Prof. John Gabrieli that shows that the difficulty people with dyslexia experience when reading could be caused by reduced plasticity in the brain. “We need to figure out a curriculum or approach that matches the differences they have,” explains Gabrieli.
A new study co-authored by Prof. John Gabrieli shows that the brains of people with dyslexia respond differently not only to words, but also objects and faces, reports Felice Freyer for The Boston Globe. The findings point to “the core biological difference in the brains of people with dyslexia,” explains Prof. John Gabrieli.
Prof. James Collins has been named one of The Boston Globe’s “2016 Bostonians of the Year” for his work developing a paper-based test that can detect the Zika virus in just a few hours. Neil Swidey notes that Collins also developed a “workflow for how this new platform could be adapted to meet future crises.”
A new drug delivery system developed by MIT researchers may help eradicate malaria and could boost medication adherence, writes Rachel Zimmerman for WBUR’s Bostonomix. "People don't take their medicines and this might be a way, someday, for Alzheimer's patients to have much better treatments and people with mental health diseases to have much better treatments," says Prof. Langer.
MIT researchers have devised a capsule that can deliver medications over extended periods of time, and could be useful in halting the spread of malaria. The Economist notes that the device could be a “useful addition to the armory being deployed against malaria. And that, alone, could save many lives a year.”
Bob Tedeschi writes for STAT that MIT researchers have developed a device that can remain in the stomach for up to two weeks, gradually releasing medication. “The capsule represents the latest effort to solve a major flaw in drug delivery,” Tedeschi explains. “Because the human stomach clears its contents multiple times daily, pill takers must dose themselves frequently.”
MIT researchers have developed a new drug delivery capsule that can deliver medication over extended periods of time, reports Claire Maldarelli for Popular Science. Once in the stomach, the capsule opens into a star shape, which “prevents the pill from leaving the stomach and entering the small intestine.”
Reuters reporter Kate Kelland writes that MIT researchers have created a new drug-delivery capsule that can stay in the stomach for up to two weeks after being swallowed. The star-shaped device could be “a powerful weapon in fighting malaria, HIV and other diseases where successful treatment depends on repeated doses of medicine.”